Mansueto Drip-Sells $4.6M of MORN Across 5 Days; Owns 37.5%

Joseph Mansueto — the founder of Morningstar (MORN) and its largest individual shareholder — filed a series of Form 4 reports last week disclosing the sale of roughly $4.6 million of MORN across five consecutive trading days, May 6 through May 12, 2026. After the May 12 close he holds 8,088,740 shares directly, down from 8,114,570 at the start of the week. The execution pattern — dozens of small lots ranging from 18 shares to 7,232 shares, priced at $166 to $180, spread across consecutive sessions — is the structural fingerprint of an algorithmic disposition under a prearranged plan, not a discretionary CEO-style block trade.

Two facts make this filing newsworthy. First: despite roughly $1.95 billion in lifetime open-market sales since 2006, Mansueto's most recent Schedule 13G/A (filed February 12, 2026) reports beneficial ownership of 14,909,759 shares, or 37.5% of Morningstar. The direct Form 4 stake of 8.09M shares is just over half of his total beneficial position; the balance sits in trusts and family entities. The drip-sales matter much less than the underlying ownership structure: Mansueto's 37.5% stake makes Morningstar effectively founder-controlled regardless of how many small lots clear in any given month.

The execution pattern at a glance

Each of May 7, 11, and 12 cleared roughly 7,250 shares total across multiple small executions at progressively higher prices — the canonical pattern of a TWAP or VWAP algorithm working a fixed share-count daily limit. The May 7 session is particularly clean: 13 separate execution slips between $166 and $180, totaling 7,250 shares, all reported on a single Form 4. The likely interpretation: a prearranged Rule 10b5-1 plan with a daily share-count cap, executed via an algorithm that splits the parent order into small child orders to minimize market impact.

The total over five sessions: 26,241 shares for approximately $4.62 million. At Mansueto's lifetime $1.95B in disclosed sells, that is well under one-tenth of a percent. The dollar amount is small relative to either his beneficial position ($2.6B at Friday's price) or his career disposition history. The story is the structure, not the size.

What this means for MORN holders

For anyone trading or holding Morningstar stock, the actionable read is: this is the kind of insider selling pattern that should NOT move the stock. Mansueto's daily share-count cap appears stable in the low-thousands range across multiple weeks, his beneficial ownership remains at 37.5%, and the absence of a tax-withholding code (`F`) or option-exercise code (`M`) on the transactions means these are pure open-market dispositions, not compensatory or restructure-driven trades.

What would change that read: a Form 144 filing announcing a substantially larger block sale, an SC 13G/A showing beneficial ownership stepping below 30%, or a clean break in the microlot daily-cap pattern (a single 100K+ share day). Subscribe to the alerts feed with the MORN ticker watch to be notified of any such filings. The 10b5-1 footnote explainer is the right primer if you want to interpret subsequent filings.

The 13G context: why this is still founder-controlled

Mansueto's February 12, 2026 SC 13G/A disclosed beneficial ownership of 14,909,759 shares (37.5%). That includes the 8.09M direct Form 4 holding plus approximately 6.8M shares held through trusts and related family entities. By contrast, the next-largest holder of Morningstar — even after stripping out passive index funds — is well below 5%. There is no other 13D or 13G-filer claiming a similar concentration. The institutional book at Morningstar is dominated by the standard passive index complex (Vanguard, BlackRock, State Street); the active conviction signal in MORN sits with Mansueto and a handful of mid-sized discretionary growth funds further down the list. For the full holder breakdown, see the MORN stock page.

A meaningful 13G amendment crossing below the 25% beneficial-ownership threshold — which would require selling roughly five million additional shares from the trust complex — is the threshold at which Morningstar starts to look like an investor-controlled company rather than a founder-controlled one. At the current drip-sale pace of ~7,250 shares a day, that would take more than two years of continuous selling.

Daniel Mansueto's parallel filings

The same February 12, 2026 13G/A cycle also reported beneficial ownership for Daniel Mansueto at 9.5% / 3,757,306 shares. Together the two related-party filings cover roughly 47% of Morningstar's outstanding equity. That is the second-most-important reference number to keep in mind whenever a Joseph Mansueto Form 4 lands: the family complex collectively controls just under half the company.

What to watch from here

1. The next Morningstar earnings release, scheduled for late July 2026 (Q2 2026 results). If the May 6-12 drip-sale pattern reflects a 10b5-1 plan, expect the plan to be paused during the pre-announcement blackout window and resumed afterward. A pause in Form 4 filings through early August followed by a resumption mid-August would confirm the plan-driven interpretation.
2. Any Form 144 filing. Form 144 (notice of proposed sale of restricted/control securities) gives advance notice of larger block sales. The current microlot pattern would NOT require Form 144; a deviation from the pattern would.
3. A 13G/A amendment. The next routine cycle is February 2027; an earlier amendment would signal a material change in beneficial ownership.

For E-E-A-T citation, the underlying Form 4 filings are publicly indexed on Joseph Mansueto's EDGAR page (reporter CIK 0001324069). The full filing list including the SC 13G/A is available from the same page. Historical Form 4 transactions back to 2006 are aggregated on Mansueto's insider profile, including the more than 11,000 reported transactions and approximately $1.95 billion in lifetime sells. For readers who want to read other founder-controlled drip-sale patterns, the insights feed aggregates Form 4 activity across the platform.